skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

Cameron, David ; Casey, Michelle ; Press, Michael ; Lindquist, Deborah ; Pienkowski, Tadeusz ; Romieu, C. Gilles ; Chan, Stephen ; Jagiello-Gruszfeld, Agnieszka ; Kaufman, Bella ; Crown, John ; Chan, Arlene ; Campone, Mario ; Viens, Patrice ; Davidson, Neville ; Gorbounova, Vera ; Raats, Johannes Isaac ; Skarlos, Dimosthenis ; Newstat, Beth ; Roychowdhury, Debasish ; Paoletti, Paolo ; Oliva, Cristina ; Rubin, Stephen ; Stein, Steven ; Geyer, Charles E.

Breast cancer research and treatment, 2008-12, Vol.112 (3), p.533-543 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
2
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

Pienta, Kenneth J. ; Machiels, Jean-Pascal ; Schrijvers, Dirk ; Alekseev, Boris ; Shkolnik, Mikhail ; Crabb, Simon J. ; Li, Susan ; Seetharam, Shobha ; Puchalski, Thomas A. ; Takimoto, Chris ; Elsayed, Yusri ; Dawkins, Fitzroy ; de Bono, Johann S.

Investigational new drugs, 2013-06, Vol.31 (3), p.760-768 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
3
Systematic Review and Pooled Estimates for the Diagnostic Accuracy of Serological Markers for Intestinal Ischemia
Systematic Review and Pooled Estimates for the Diagnostic Accuracy of Serological Markers for Intestinal Ischemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Systematic Review and Pooled Estimates for the Diagnostic Accuracy of Serological Markers for Intestinal Ischemia

Evennett, Nicholas J. ; Petrov, Maxim S. ; Mittal, Anubhav ; Windsor, John A.

World journal of surgery, 2009-07, Vol.33 (7), p.1374-1383 [Periódico revisado por pares]

New York: Springer-Verlag

Texto completo disponível

Citações Citado por
4
Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma
Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

Moreau, Philippe ; Karamanesht, Ievgenii I. ; Domnikova, Natalia ; Kyselyova, Maryna Y. ; Vilchevska, Kateryna V. ; Doronin, Vadim A. ; Schmidt, Alexander ; Hulin, Cyrille ; Leleu, Xavier ; Esseltine, Dixie-Lee ; Venkatakrishnan, Karthik ; Skee, Donna ; Feng, Huaibao ; Girgis, Suzette ; Cakana, Andrew ; van de Velde, Helgi ; Deraedt, William ; Facon, Thierry

Clinical pharmacokinetics, 2012-12, Vol.51 (12), p.823-829 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
5
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

Miles, David ; Baselga, José ; Amadori, Dino ; Sunpaweravong, Patrapim ; Semiglazov, Vladimir ; Knott, Adam ; Clark, Emma ; Ross, Graham ; Swain, Sandra M.

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.89-99 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
6
Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries
Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries
Material Type:
Artigo 		Adicionar ao Meu Espaço

Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries

Danne, T. ; Battelino, T. ; Jarosz-Chobot, P. ; Kordonouri, O. ; Pánkowska, E. ; Ludvigsson, J. ; Schober, E. ; Kaprio, E. ; Saukkonen, T. ; Nicolino, M. ; Tubiana-Rufi, N. ; Klinkert, C. ; Haberland, H. ; Vazeou, A. ; Madacsy, L. ; Zangen, D. ; Cherubini, V. ; Rabbone, I. ; Toni, S. ; de Beaufort, C. ; Bakker-van Waarde, W. ; van den Berg, N. ; Volkov, I. ; Barrio, R. ; Hanas, R. ; Zumsteg, U. ; Kuhlmann, B. ; Aebi, C. ; Schumacher, U. ; Gschwend, S. ; Hindmarsh, P. ; Torres, M. ; Shehadeh, N. ; Phillip, M.

Diabetologia, 2008-09, Vol.51 (9), p.1594-1601 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
7
Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations
Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations

Prokofyeva, Darya ; Bogdanova, Natalia ; Dubrowinskaja, Natalia ; Bermisheva, Marina ; Takhirova, Zalina ; Antonenkova, Natalia ; Turmanov, Nurzhan ; Datsyuk, Ihor ; Gantsev, Shamil ; Christiansen, Hans ; Park-Simon, Tjoung-Won ; Hillemanns, Peter ; Khusnutdinova, Elza ; Dörk, Thilo

Breast cancer research and treatment, 2013-01, Vol.137 (2), p.533-539 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
8
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

Cristofanilli, Massimo ; Johnston, Stephen R. D. ; Manikhas, Alexey ; Gomez, Henry L. ; Gladkov, Oleg ; Shao, Zhimin ; Safina, Sufia ; Blackwell, Kimberly L. ; Alvarez, Ricardo H. ; Rubin, Stephen D. ; Ranganathan, Sulabha ; Redhu, Suman ; Trudeau, Maureen E.

Breast cancer research and treatment, 2013, Vol.137 (2), p.471-482 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
9
A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
Material Type:
Artigo 		Adicionar ao Meu Espaço

A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components

Pfeiffer, Norbert ; Traverso, Carlo E. ; Lorenz, Katrin ; Saarela, Ville ; Liinamaa, Johanna ; Uusitalo, Hannu ; Astakhov, Yury ; Boiko, Ernest ; Ropo, Auli

Advances in therapy, 2014-12, Vol.31 (12), p.1228-1246 [Periódico revisado por pares]

Heidelberg: Springer Healthcare

Texto completo disponível

Citações Citado por
10
Patient Age and CYP2D64/CYP2D63 Genotype on Maximal Heart Rate in Patients after Acute Coronary Syndrome Treated with Bisoprolol
Patient Age and CYP2D64/CYP2D63 Genotype on Maximal Heart Rate in Patients after Acute Coronary Syndrome Treated with Bisoprolol
Material Type:
Artigo 		Adicionar ao Meu Espaço

Patient Age and CYP2D64/CYP2D63 Genotype on Maximal Heart Rate in Patients after Acute Coronary Syndrome Treated with Bisoprolol

Shumkov, V. A. ; Zagorodnikova, K. A. ; Boldueva, S. A. ; Murzina, A. A. ; Petrova, V. B.

Advances in gerontology, 2021-10, Vol.11 (4), p.362-367 [Periódico revisado por pares]

Moscow: Pleiades Publishing

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (101)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (104)
  2. Livros  (3)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (16)
  2. 1998Até2004  (19)
  3. 2005Até2009  (21)
  4. 2010Até2015  (31)
  5. Após 2015  (21)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (94)
  2. Japonês  (14)
  3. Ucraniano  (3)
  4. Francês  (1)
  5. Alemão  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.